MTOR and diffuse large B-cell lymphoma: PTEN mutations are reported in 10.6% of DLBCL (12% of GCB-DLBCL and 9% of ABC-DLBCL) and correlate with the induction of genes involved in the regulation of Akt/mTOR signaling and metabolism (92).